Abstract
In general, prevention is considered an epidemiologically good strategy because it decreases the likelihood of animal disease outbreaks (and thus epidemics), mainly by hindering the infectious agent spread and thereby lowering the number of diseased animals and the economical losses. Similarly, surveillance, i.e. monitoring and early detection of diseased animals, is generally considered as an epidemiologically good strategy because it increases the probability of controlling the outbreak before it reaches an epidemic scale. Both prevention and surveillance are proactive rather than reactive approaches, but there seems to be no clear a priori advantage of prevention over surveillance or vice versa. Nonetheless, some suggest that prevention offers better disease control results than surveillance and thus that both can be mutually exclusive. This discussion paper challenges this assumption and argues that both approaches should be seen as complimentary measures rather than opposing actions. A blended strategy that builds upon synergies between the prevention and surveillance approaches, will offer a stronger defense against epidemics than a single approach. The specific combination of prevention and surveillance measures depends on a series of factors, of which availability of technological innovations and economic benefits can be one. To bridge the suggested dichotomy between prevention and surveillance, we use a set of ethical arguments comprised of three principles: the ‘right-to-know’, the ‘right-not-to-know’, and the ‘duty-to-know’. For important animal diseases and with the emergence of advanced diagnostics/ monitoring technologies, the balance between these three principles shifts away from the right not to know towards a duty to know. This set of principles thus demonstrates the importance of surveillance within the overall strategy. We argue that, in a combined disease control strategy, prevention must be the most important component, which we would therefore term a ‘vigilant prevention strategy’.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Beauchamp, T.L. and Childress, J.F. (2001). Principles of biomedical ethics (5th ed.). Oxford University Press, New York, USA, 472 pp. (First edition: 1979).
Dürr, S., Grimm, H., Aerts, S. and Hartnack, S. (2010). ADIM – eine Möglichkeit zur Beurteilung der ethischen Vertretbarkeit von Tierseuchenbekämpfungsmassnahmen? Jahreskonferenz of the VPH-Institute, Berne, Switzerland, (December 2, 2010).
Evers, J., Aerts, S. and De Tavernier, J. (2008). An ethical argument in favor of nano-enabled diagnostics in livestock. Nanoethics 2: 163–178.
Feinberg, J. (1986). Harm to Self. Oxford University Press, Oxford, UK, 448 pp.
Hartnack, S., Grimm, H., Kunzmann, P., Doherr, M.G. and Aerts, S. (2009). Ethics for vets: can ethics help to improve animal disease control? In: Millar, K., Hobson West, P. and Nerlich, B. (eds.) Ethical futures: bioscience and food horizons. Wageningen Academic Publishers, Wageningen, the Netherlands. pp. 148–153.
Mepham, B. (1996). A framework for the ethical analysis of novel foods: the ethical matrix. Journal of Agricultural and Environmental Ethics 12: 165–176.
Acknowledgment
The article of Evers et al. (2008)) was an inspiring source for this discussion paper, and the authors would like to thank Johan Evers for his comments on this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Wageningen Academic Publishers
About this chapter
Cite this chapter
Aerts, S., Boonen, R., De Tavernier, J. (2012). An ethical argument for vigilant prevention. In: Potthast, T., Meisch, S. (eds) Climate change and sustainable development. Wageningen Academic Publishers, Wageningen. https://doi.org/10.3920/978-90-8686-753-0_39
Download citation
DOI: https://doi.org/10.3920/978-90-8686-753-0_39
Publisher Name: Wageningen Academic Publishers, Wageningen
Online ISBN: 978-90-8686-753-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)